{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1034.582","meta":{"versionId":"17","lastUpdated":"2021-03-09T01:00:17.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"American Academy of Neurology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-03-09"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.582","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1034.582"}],"version":"20210309","name":"DiabetesScreeningWithFastingComponentLOINC","title":"Diabetes Screening with Fasting Component (LOINC)","status":"active","experimental":false,"date":"2021-03-09T01:00:17-05:00","publisher":"American Academy of Neurology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This value set contains LOINC concepts for diabetes screening with a fasting component excluding gestational diabetes.),(Data Element Scope: The intent of this data element is to identify people who have participated in diabetes screening with a fasting component.),(Inclusion Criteria: The intent of this data element is to identify people who have participated in diabetes screening with a fasting component.),(Exclusion Criteria: Excludes screening or assessment without a fasting component and for gestational diabetes and blood glucose screening methods using bodily substances other than blood or urine.)","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"21004-7","display":"Glucose tolerance [Interpretation] in Serum or Plasma"},{"code":"49688-5","display":"Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"},{"code":"50586-7","display":"Glucose tolerance 3 hours panel - Serum or Plasma"},{"code":"50587-5","display":"Glucose tolerance 4 hours panel - Serum or Plasma"},{"code":"50588-3","display":"Glucose tolerance 5 hours panel - Serum or Plasma"},{"code":"50589-1","display":"Glucose tolerance 6 hours panel - Serum or Plasma"},{"code":"55399-0","display":"Diabetes tracking panel"},{"code":"72171-2","display":"Glucose tolerance 2 hours panel - Serum or Plasma"},{"code":"93794-6","display":"Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma"}]}]},"expansion":{"identifier":"urn:uuid:f348f7f6-b56a-4407-a8e8-7eb678c8e9db","timestamp":"2023-12-10T20:47:21-05:00","total":9,"contains":[{"system":"http://loinc.org","version":"2.76","code":"21004-7","display":"Glucose tolerance [Interpretation] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.76","code":"49688-5","display":"Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"},{"system":"http://loinc.org","version":"2.76","code":"50586-7","display":"Glucose tolerance 3 hours panel - Serum or Plasma"},{"system":"http://loinc.org","version":"2.76","code":"50587-5","display":"Glucose tolerance 4 hours panel - Serum or Plasma"},{"system":"http://loinc.org","version":"2.76","code":"50588-3","display":"Glucose tolerance 5 hours panel - Serum or Plasma"},{"system":"http://loinc.org","version":"2.76","code":"50589-1","display":"Glucose tolerance 6 hours panel - Serum or Plasma"},{"system":"http://loinc.org","version":"2.76","code":"55399-0","display":"Diabetes tracking panel"},{"system":"http://loinc.org","version":"2.76","code":"72171-2","display":"Glucose tolerance 2 hours panel - Serum or Plasma"},{"system":"http://loinc.org","version":"2.76","code":"93794-6","display":"Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma"}]}}